Pinnacle Financial Partners (Georgia)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.25M Buy
193,225
+36,936
+24% +$2.01M 0.06% 243
2026
Q1
$9.81M Buy
156,289
+26,107
+20% +$2.09M 0.08% 210
2025
Q4
$12.4M Buy
+130,182
New +$12.8M 0.09% 172

Other funds holding BSX

Pinnacle Financial Partners (Georgia)'s BSX Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) increased its Boston Scientific (BSX) stake by 24% in Q2 2026, buying an estimated $2.01M and bringing the position to 193,225 shares worth $8.25M. The position accounts for 0.06% of the portfolio, ranked #243.

Pinnacle Financial Partners (Georgia) first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.4M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 193,225 shares of Boston Scientific worth $8.25M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) bought 36,936 Boston Scientific shares in Q2 2026, an estimated $2.01M.
  • Boston Scientific made up 0.06% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #243 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Financial Partners (Georgia)'s Boston Scientific position peaked at $12.4M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.